Dale Blaise
Family Medicine · Murphysboro, ILNPI 1770557472
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 294 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,405 and has fallen 80.9% since, to $268 in 2024. Among family medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 294 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$611
- AstraZeneca$591
- AbbVie$410
- Amgen$368
- GSK$310
- Pfizer$242
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,333100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $611 |
| AstraZeneca | 41 | $591 |
| AbbVie(2 entities) | 27 | $410 |
| Amgen | 27 | $368 |
| GSK | 22 | $310 |
| Pfizer | 19 | $242 |
| Boehringer Ingelheim | 11 | $191 |
| Novartis | 13 | $185 |
| Merck | 12 | $174 |
| Johnson & Johnson | 15 | $168 |
| Novo Nordisk | 10 | $152 |
| Abbott | 9 | $150 |
| Bayer | 6 | $109 |
| Nestle Healthcare Nutrition Inc. | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $108 |
| Astellas Pharma US Inc | 6 | $80 |
| Mylan Specialty L.p. | 4 | $51 |
| Sunovion Pharmaceuticals Inc. | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 3 | $31 |
| UCB, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
How this compares
$4,344 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 285 | $96,667 |
| JardianceEmpagliflozin | 28 | $22,469 |
| MyrbetriqMirabegron | 21 | $13,599 |
| FarxigaDapagliflozin Propanediol | 28 | $12,551 |
| XareltoRivaroxaban | 18 | $11,500 |
| NamzaricMemantine Hcl/Donepezil Hcl | 29 | $8,630 |
| TrintellixVortioxetine Hydrobromide | 32 | $7,893 |
| TradjentaLinagliptin | 27 | $7,453 |
| Atorvastatin Calcium | 301 | $3,460 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $2,778 |
| Gabapentin | 128 | $2,769 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,722 |
| Potassium Chloride | 121 | $2,515 |
| Metoprolol Succinate | 145 | $2,172 |
| Levothyroxine Sodium | 151 | $1,791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $242 | $96,667285 claims |
| Boehringer IngelheimJardiance, Tradjenta | $191 | $29,92255 claims |
| Astellas Pharma US IncMyrbetriq | $80 | $13,59921 claims |
| AstraZenecaFarxiga | $591 | $12,55128 claims |
| Johnson & JohnsonXarelto | $168 | $11,50018 claims |
| AbbVieNamzaric | $410 | $8,63029 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $108 | $7,89332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Murphysboro
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.